Fundz

Anumana reported raising $32 Million in an initial SEC Form D filing, from an offering of $32 Million

PRIVATENov 17, 2022

Amount Raised

$32 Million

$32 Million sold, per SEC Form D (first sale Nov 4, 2022)

Round Type

Venture

CambridgeBiotechnologyArtificial IntelligenceMachine LearningHealth Diagnostics

Quick answer

Anumana raised $32 Million in a funding round, dated November 4, 2022. Anumana is based in Cambridge, Massachusetts, United States.

How much did Anumana raise?
Anumana raised $32 Million in a funding round on November 4, 2022.
What does Anumana do?
Anumana, an AI-driven health technology company and portfolio company of nference and Mayo Clinic Platform, is harnessing industry-leading AI and translational science to unlock the electrical language of the heart as..
Where is Anumana based and how big is it?
Anumana is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Anumana?
Fundz holds 1 contact at Anumana, including the VP of Clinical Research. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Health Diagnostics and Biotechnology around the same time

Companies in the same sectors as Anumana that raised within 45 days of this round, from Fundz verified event records.

  • In-Med Prognostics raised $2.1M (Seed) on December 12, 2022.
  • Turbine raised $20M (Series A) on November 22, 2022.
  • Ibex Medical Analytics raised $10M (Funding Round) on November 9, 2022.
  • Carta Healthcare raised $20M (Series B) on November 2, 2022.
  • Optellum raised $14M (Series A) on September 27, 2022.
  • RegASK raised $10M (Series A) on December 15, 2022.

Who to call at Anumana, and when

A new round usually means Anumana is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Anumana raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Anumana, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Anumana. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Anumana

Location

ONE MAIN STREET

Cambridge, Massachusetts, United States

About

Anumana, an AI-driven health technology company and portfolio company of nference and Mayo Clinic Platform, is harnessing industry-leading AI and translational science to unlock the electrical language of the heart as never before. Anumana algorithms have been developed, trained, and validated using clinical data from Mayo Clinic and other leading institutions to detect hidden diseases using ECG-AI and enhance and improve EP procedures through real-time AI techniques. Multiple Anumana algorithms have received FDA Breakthrough Device Designation and are currently undergoing rigorous clinical trial validation. Anumana software devices are designed for real-world physician use, integrating into existing workflows at the point-of-care, thereby reducing costs and enhancing quality of life. Anumana algorithms are investigational medical devices and have not yet received regulatory approval or clearance. For more information, visit anumana.ai and follow Anumana on LinkedIn and Twitter.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Anumana raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSamir A., VP of Clinical ResearchSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Anumana's next move

See what Strategic adds

Anumana raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.